Rare disease online funding raising platforms make sure that people get the right help at the right time to afford life-saving treatments.
A rare disease online donation crowdfunding movement in India raised INR 125+ crore in 14 months (January 2021 to February 2022), for patients fighting rare diseases like Spinal Muscular Atrophy (SMA type 1 & 2), Gaucher’s disease, Pompe’s disease, rare forms of cancer and others. This finding is reported in India’s leading integrated healthcare financing platform, ImpactGuru.com.
In a joint statement, ImpactGuru.com Co-Founders Piyush Jain and Khushboo Jain said, “We applaud the government’s efforts to solve the issue of funding rare diseases and believe crowdfunding as one of the platforms for patients to receive funds whilst encouraging communities to donate for larger good under National Policy for Rare Diseases 2021”.
Donation crowdfunding platforms have changed people's belief that how high the treatment cost is, there is enough generosity for people to find financing and receive access to quality healthcare.
The fundraisers in most of the events belonged to middle-class and lower-middle-class families that lacked access to high-cost gene therapy and other medicines, which are prescribed by Indian doctors for treating patients with rare diseases.
Over 80% of donations in 1200+ rare disease campaigns came from resident Indian donors. Among them, Mumbai based patients have raised the highest at INR 35 crore followed by patients residing in Bangalore, Ahmedabad, Hyderabad, and Delhi.
The single highest donation received on one of the rare disease fundraising campaigns was INR 56 lakh. A record-breaking event was witnessed in one of the rare disease crowdfunding campaigns where 265,000+ Indian donors contributed towards achieving the goal amount. Printing the QR Code on T-Shirts is the innovative method used for obtaining donations.
Advertisement
At present treatments for rare genetic diseases are not covered by health insurance companies and also lack support from government schemes.
Advertisement
Source-Medindia